[1] |
谢辛,苟文丽.妇产科学.8版[M].北京:人民卫生出版社,2013:268–274.
|
[2] |
姚红梅,郭静,石秀玲. VEGF CD44v6 MMP-9在子宫内膜异位症组织中的表达及临床意义[J]. 2013, 36(2): 124–126.
|
[3] |
Giudice LC. Clinical practice. Endometriosis[J]. N Engl J Med, 2010, 362(25): 2389–2398.
|
[4] |
Lim HJ, Wang H.Uterine disorders and pregnancy complications: insights from mouse models[J]. J Clin Invest, 2010, 120(4): 1004–1015.
|
[5] |
Ngô C, Nicco C, Leconte M, et al. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo[J]. J Pathol, 2010, 222(2): 148–157.
|
[6] |
Khoufache K, Bondza PK, Harir N, et al. Soluble human IL-1 receptor type 2 inhibits ectopic endometrial tissue implantation and growth: identification of a novel potential target for endometriosis treatment[J]. Am J Pathol, 2012, 181(4): 1197–1205.
|
[7] |
Leconte M, Nicco C, Ngô C, et al. The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice[J]. Am J Pathol, 2011, 179(2): 880–889.
|
[8] |
Uchida M, Kobayashi O. Sequential observation of implanted endometriosis by laparoscopy in rats: correlation between the prevalence rate and the estrous cycle[J]. J Pharmacol Sci, 2013, 121(4): 299–304.
|
[9] |
王洁,吴素慧,尚海霞. 性成熟雌性SD大鼠动情周期的观察[J]. 当代医学,2013, 19(28): 25–26.
|
[10] |
Uchida M, Kobayashi O. Sequential observation of implanted endometriosis by laparoscopy in rats: correlation between the prevalence rate and the estrous cycle[J]. J Pharmacol Sci, 2013, 121(4): 299–304.
|
[11] |
Feng D, Menger MD, Laschke MW. Vascular disrupting effects of combretastatin A4 phosphate on murine endometriotic lesions[J]. Fertil Steril, 2013, 100(5): 1459–1467.
|
[12] |
Lee HJ, Lee HJ, Lee JM, et al. Ultrasmall superparamagnetic iron oxides enhanced MR imaging in rats with experimentally induced endometriosis[J]. Magn Reson Imaging, 2012, 30(6): 860–868.
|
[13] |
Schwager K, Bootz F, Imesch P, et al. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model[J]. Hum Reprod, 2011, 26(9): 2344–2352
|
[14] |
周玲,钱志红,任琼珍. 皮下注射子宫内膜法建立Lewis大鼠腹壁子宫内膜异位症模型[J]. 江苏医药,2012, 38(13): 1513–1515.
|
[15] |
Huniadi CA, Pop OL, Antal TA, et al. The effects of ulipristal on Bax/Bcl-2, cytochrome c, Ki-67 and cyclooxygenase-2 expression in a rat model with surgically induced endometriosis[J]. Eur J Obstet Gynecol Reprod Biol, 2013, 169(2): 360–365.
|
[16] |
Altan ZM, Denis D, Kagan D, et al. A long-acting tumor necrosis factor alpha-binding protein demonstrates activity in both in vitro and in vivo models of endometriosis[J]. J Pharmacol Exp Ther, 2010, 334(2): 460–466.
|
[17] |
崔阳阳,孙伟伟,赵瑞华. 子宫内膜异位症动物模型研究进展[J]. 中国实验动物学报,2013, 21(5): 86–89.
|
[18] |
彭艳,何援利. 大鼠子宫内膜异位症动物模型建立方法的比较[J]. 重庆医学,2012, 41(25): 2619–2620.
|
[19] |
Pullen N, Birch CL, Douglas GJ, et al. The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies[J]. Hum Reprod Update, 2011, 17(6): 791–802.
|
[20] |
Grechukhina O, Petracco R, Popkhadze S, et al. A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis[J]. EMBO Mol Med, 2012, 4(3): 206–217.
|